Principal Display Panel (50 mg Capsule Bottle Label Sample)
Store this medication at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Please refer to the USP Controlled Room Temperature guidelines. Keep the medicine in its original package and follow the dosage instructions provided in the accompanying Prescribing Information. Each capsule contains 50 mg of ritlecitinib, which is equivalent to 80.13 mg of ritlecitinib tosylate. This medication is distributed by U.S. Pharmaceuticals, a division of Pfizer Inc. located in New York, NY. This is a professional sample and not for sale. Always dispense this medication with the Medication Guide. The National Drug Code (NDC) for this product is 63539-334-28. The product is called Litfulo™ and it is available in capsule form at a strength of 50mg. Do not crush, split, or chew the capsules and avoid consuming the desiccant. Each package contains 28 capsules and this medication requires a prescription. The GTIN for this product is 00363539334283.*
